USA - NYSE:OMI - US6907321029 - Common Stock
The current stock price of OMI is 5.51 USD. In the past month the price increased by 15.51%. In the past year, price decreased by -58.91%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| MCK | MCKESSON CORP | 23.94 | 99.71B | ||
| COR | CENCORA INC | 21.48 | 64.51B | ||
| CAH | CARDINAL HEALTH INC | 19.65 | 38.46B | ||
| HSIC | HENRY SCHEIN INC | 13.7 | 7.74B | ||
| AHCO | ADAPTHEALTH CORP | 30.23 | 1.27B | ||
| AHG | AKSO HEALTH GROUP | N/A | 934.25M | ||
| ATPC | AGAPE ATP CORP | N/A | 63.01M | ||
| WGRX | WELLGISTICS HEALTH INC | N/A | 105.12M | ||
| COSM | COSMOS HEALTH INC | N/A | 30.81M | ||
| VRAX | VIRAX BIOLABS GROUP LTD | N/A | 2.54M | ||
| POM | POMDOCTOR LTD - ADR | N/A | 549.56M |
Owens & Minor, Inc. is a healthcare solutions company, which engages in the product manufacturing and delivery, home health supply, and perioperative services to support care through the hospital and into the home. The company is headquartered in Glen Allen, Virginia and currently employs 13,500 full-time employees. The firm operates through two segments: Products & Healthcare Services and Patient Direct. The Products & Healthcare Services segment includes its United States distribution division (Medical Distribution), including an outsourced logistics and value-added services business, and its Global Products division, which manufactures and sources medical surgical products through its production and kitting operations. The company provides medical supplies and solutions for infection prevention across acute, alternate site and consumer channels. The Patient Direct segment includes its home healthcare divisions (Byram and Apria). The segment provides delivery of disposable medical supplies sold directly to patients and home health agencies and is a provider of integrated home healthcare equipment and related services in the United States.
OWENS & MINOR INC
10900 Nuckols Road, Suite 400
Glen Allen VIRGINIA 23261 US
CEO: Edward A. Pesicka
Employees: 23200
Phone: 18047237000
Owens & Minor, Inc. is a healthcare solutions company, which engages in the product manufacturing and delivery, home health supply, and perioperative services to support care through the hospital and into the home. The company is headquartered in Glen Allen, Virginia and currently employs 13,500 full-time employees. The firm operates through two segments: Products & Healthcare Services and Patient Direct. The Products & Healthcare Services segment includes its United States distribution division (Medical Distribution), including an outsourced logistics and value-added services business, and its Global Products division, which manufactures and sources medical surgical products through its production and kitting operations. The company provides medical supplies and solutions for infection prevention across acute, alternate site and consumer channels. The Patient Direct segment includes its home healthcare divisions (Byram and Apria). The segment provides delivery of disposable medical supplies sold directly to patients and home health agencies and is a provider of integrated home healthcare equipment and related services in the United States.
The current stock price of OMI is 5.51 USD. The price increased by 4.75% in the last trading session.
OMI does not pay a dividend.
OMI has a ChartMill Technical rating of 3 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
The PE ratio for OWENS & MINOR INC (OMI) is 3.77. This is based on the reported non-GAAP earnings per share of 1.46 and the current share price of 5.51 USD.
OWENS & MINOR INC (OMI) has a market capitalization of 425.59M USD. This makes OMI a Small Cap stock.
The outstanding short interest for OWENS & MINOR INC (OMI) is 10.48% of its float.
ChartMill assigns a technical rating of 3 / 10 to OMI. When comparing the yearly performance of all stocks, OMI is a bad performer in the overall market: 95.96% of all stocks are doing better.
ChartMill assigns a fundamental rating of 3 / 10 to OMI. OMI has a medium profitability rating, but doesn't score so well on its financial health evaluation.
Over the last trailing twelve months OMI reported a non-GAAP Earnings per Share(EPS) of 1.46. The EPS decreased by -13.1% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -28.95% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
12 analysts have analysed OMI and the average price target is 6.26 USD. This implies a price increase of 13.66% is expected in the next year compared to the current price of 5.51.
For the next year, analysts expect an EPS growth of -32.09% and a revenue growth -74.03% for OMI